Nivolumab-Ipilimumab for Localized Microsatellite Instability-High Gastric/Gastroesophageal Junction Adenocarcinoma: The Phase 2 NEONIPIGA Nonrandomized Clinical Trial. (PubMed, JAMA Oncol) - Oct 16, 2026 - P2 | "The high pCR rates and durable responses observed may provide useful information for designing future clinical studies, including randomized trials investigating organ-preserving strategies. ClinicalTrials.gov Identifier: NCT04006262."
Clinical • Journal • MSI-H • P2 data • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Microsatellite Instability • Oncology • Solid Tumor • MSI
|
|
Antoine Adenis; Christelle de la Fouchardiere; Christophe Louvet; David Tougeron; Dewi Vernerey; Guillaume Piessen; Jeremie H Lefevre; Julie Henriques; Magali Svrcek; Marie-Line Garcia-Larnicol; Marine Jary; Romain Cohen; Thierry André; Thomas Samaille
|